FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 21 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,681,000 | +49.0% | 511,799 | +24.3% | 0.00% | 0.0% |
| Q3 2016 | $3,813,000 | +55.9% | 411,727 | +6.9% | 0.00% | 0.0% |
| Q2 2016 | $2,446,000 | -61.8% | 385,144 | -60.8% | 0.00% | 0.0% |
| Q1 2016 | $6,401,000 | -18.5% | 981,815 | +1.4% | 0.00% | -50.0% |
| Q4 2015 | $7,853,000 | +79.5% | 968,305 | +62.2% | 0.00% | +100.0% |
| Q3 2015 | $4,376,000 | -28.0% | 596,994 | +0.7% | 0.00% | 0.0% |
| Q2 2015 | $6,077,000 | +3314.0% | 592,874 | +2978.4% | 0.00% | – |
| Q1 2015 | $178,000 | +223.6% | 19,259 | +147.1% | 0.00% | – |
| Q4 2014 | $55,000 | – | 7,795 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 1,667,377 | $15,440,000 | 9.38% |
| GREAT POINT PARTNERS LLC | 2,769,425 | $25,645,000 | 6.54% |
| Opaleye Management Inc. | 630,000 | $5,834,000 | 3.05% |
| Vivo Capital, LLC | 855,000 | $7,917,000 | 2.47% |
| DAFNA Capital Management LLC | 278,067 | $2,575,000 | 1.79% |
| RA Capital Management | 1,820,138 | $16,854,000 | 1.74% |
| SENZAR ASSET MANAGEMENT, LLC | 523,397 | $4,846,656,000 | 1.25% |
| Perceptive Advisors | 1,373,284 | $12,717,000 | 0.82% |
| Monashee Investment Management LLC | 225,000 | $2,084,000 | 0.73% |
| NEXTHERA CAPITAL LP | 125,000 | $1,158,000 | 0.71% |